Telix Pharmaceuticals Correlations

TLX Stock

18.30 0.06 0.33%

The current 90-days correlation between Telix Pharmaceuticals and Delek Logistics Partners is -0.2 (i.e., Good diversification). The correlation of Telix Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Telix Pharmaceuticals Correlation With Market

Significant diversification

The correlation between Telix Pharmaceuticals Limited and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals Limited and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Moving together with Telix Stock

0.68	VALN	Valneva SE ADR	Pair Corr
0.69	MIRM	Mirum Pharmaceuticals	Pair Corr
0.62	MNPR	Monopar Therapeutics	Pair Corr
0.67	VIGL	Vigil Neuroscience	Pair Corr

Moving against Telix Stock

0.78	MBIO	Mustang Bio	Pair Corr
0.59	MDXG	MiMedx Group	Pair Corr
0.57	MBRX	Moleculin Biotech	Pair Corr
0.55	MGNX	MacroGenics	Pair Corr
0.42	MCRB	Seres Therapeutics	Pair Corr
0.42	VANI	Vivani Medical	Pair Corr
0.31	DNTH	Dianthus Therapeutics	Pair Corr
0.6	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.6	MNKD	MannKind Corp	Pair Corr
0.59	VERA	Vera Therapeutics	Pair Corr
0.55	MLEC	Moolec Science SA	Pair Corr
0.46	DSGN	Design Therapeutics	Pair Corr
0.36	DRMA	Dermata Therapeutics	Pair Corr
0.35	VERU	Veru Inc	Pair Corr
0.77	VINC	Vincerx Pharma Earnings Call Today	Pair Corr
0.73	MRKR	Marker Therapeutics	Pair Corr
0.72	VKTX	Viking Therapeutics	Pair Corr
0.69	DYAI	Dyadic International	Pair Corr

Related Correlations Analysis

	STM	DKL	SNCY	MCHP	ODFL	GFS	FLYX	TORO
STM		-0.36	0.03	0.78	-0.13	0.32	-0.03	-0.06	STM
DKL	-0.36		0.02	-0.32	-0.08	-0.33	0.24	0.07	DKL
SNCY	0.03	0.02		0.43	0.82	0.51	0.36	0.52	SNCY
MCHP	0.78	-0.32	0.43		0.19	0.5	0.03	0.22	MCHP
ODFL	-0.13	-0.08	0.82	0.19		0.56	0.15	0.46	ODFL
GFS	0.32	-0.33	0.51	0.5	0.56		-0.13	0.55	GFS
FLYX	-0.03	0.24	0.36	0.03	0.15	-0.13		-0.24	FLYX
TORO	-0.06	0.07	0.52	0.22	0.46	0.55	-0.24		TORO
	STM	DKL	SNCY	MCHP	ODFL	GFS	FLYX	TORO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ODFL	+ 0.82	SNCY
MCHP	+ 0.78	STM
GFS	+ 0.56	ODFL
TORO	+ 0.55	GFS
TORO	+ 0.52	SNCY
GFS	+ 0.51	SNCY

High negative correlations

DKL	- 0.36	STM
GFS	- 0.33	DKL
MCHP	- 0.32	DKL
TORO	- 0.24	FLYX
FLYX	- 0.13	GFS
ODFL	- 0.13	STM

Risk-Adjusted Indicators

There is a big difference between Telix Stock performing well and Telix Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Telix Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
STM	2.24	(0.07)	0.00	(0.07)	0.00	0.00	6.64	(4.26)	16.28
DKL	1.02	0.18	0.15	0.32	0.95	(1.11)	2.92	(1.98)	6.06
SNCY	2.19	(0.05)	0.00	(0.04)	0.00	0.00	4.92	(4.19)	15.02
MCHP	2.03	(0.06)	0.00	(0.04)	0.00	0.00	3.78	(5.01)	20.48
ODFL	1.59	(0.18)	0.00	(0.14)	0.00	0.00	2.54	(3.39)	13.98
GFS	1.94	(0.11)	0.00	(0.10)	0.00	0.00	5.54	(4.87)	14.87
FLYX	4.03	0.52	0.11	(0.37)	4.22	(4.82)	9.35	(7.55)	25.27
TORO	1.90	(0.18)	0.00	(1.03)	0.00	0.00	3.99	(4.10)	12.94

Telix Pharmaceuticals Corporate Management

Kevin MBA	Chief Medicine	Profile
Richard MBA	Chief Therapeutics	Profile
BSc BSc	Chief Scientist	Profile
Lena LLB	Group Counsel	Profile
Christian Davis	EMEA Marketing	Profile
Darren PharmD	Group Officer	Profile
Darren Patti	Group Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC